Pan American Health Organization · Version 1, 23 July 2020
Operational guidance for health systems implementing 3–6 month ARV dispensing to stable people living with HIV.
- Issuer
- Pan American Health Organization
- Edition
- Version 1, 23 July 2020
- Audience
- Drug supply management units, pharmacotherapy committees, national and local HIV/AIDS programmes, comprehensive care services, pharmaceutical services, community partners
- Evidence
- Expert consensus based on WHO differentiated care strategy
- Reviewed
- 19 Oct 2026 · GMJ
What this guideline says
GMJ summary
These guidelines from the Pan American Health Organization provide a systematic framework for implementing multi-month dispensing (MMD) of antiretrovirals within integrated drug supply management systems. The guidance addresses prescription, distribution, and dispensing of ARVs for 3–6 months to clinically stable people living with HIV, with particular emphasis on maintaining treatment continuity during the COVID-19 pandemic and reducing clinic visit frequency.
The document defines clinically stable persons as those on ART for at least one year with no adverse reactions requiring regular monitoring, no current illness or pregnancy, not breastfeeding, clear understanding of lifelong treatment adherence, and two consecutive viral load tests below 1,000 copies/ml. The guidelines cover all essential supply chain processes including regulatory requirements, needs estimation, procurement, storage, distribution, and various dispensing modalities including community-based and home delivery options.
Key operational requirements include updated prescription and dispensing regulations allowing 3–6 month validity, information systems tracking patient prescription and dispensing, adequate storage capacity at local levels, and trained human resources in pharmaceutical care and inventory management. The guidance emphasizes maintaining safety stocks of at least 6 months for international procurement and implementing Good Storage and Distribution Practices throughout the supply chain.
Key points
For clinicians — doses and thresholds as stated in the guideline
- Multi-month dispensing of 3–6 months of ARVs is recommended for clinically stable people living with HIV: those on ART ≥1 year, no adverse reactions requiring monitoring, not pregnant/breastfeeding, and two consecutive viral loads <1,000 copies/ml
- Safety stock levels should correspond to replenishment lead time at each level; for international procurement, minimum 6 months safety stock is recommended
- Prescription format must specify total quantity for the number of months stipulated (e.g., if daily dose is 1 tablet for 3 months, quantity is 90 tablets)
- Alternative pharmaceutical packages in suitable quantities for MMD should be included, such as 90-tablet bottles for commonly used fixed-dose combinations
- Storage facilities must comply with Good Storage Practices with temperature and humidity control, avoiding direct light exposure
- Local level orders should include sufficient quantity to cover lead time consumption (an additional 1–2 months of average monthly consumption)
- Home delivery requires trained personnel qualified in medication handling, preservation, and rational use information; confidentiality of patient information must be ensured
- Monitor the absolute error between ARV consumption and estimation monthly; when results fall outside ±5% difference, investigate causes to improve estimation processes
Patient groups for differentiated HIV care
Table extracted from the guideline
| Group | Clinical status | Care needs |
|---|---|---|
| Group 1 | PLHIV not yet on ART, well (CD4 >500) | ART initiation + adherence support |
| Group 2 | PLHIV not on ART with advanced infection | Clinical measures and accelerated care |
| Group 3 | PLHIV on ART, clinically unstable | Careful monitoring, adherence support, timely ART changes |
| Group 4 | PLHIV on ART, clinically stable (majority) | Reduced clinic visits, community dispensing, multi-month ARVs |
Source: Pan American Health Organization, Guidelines for the implementation of multi-month dispensing of antiretrovirals. Reproduced in summary form.
From the guideline
Verbatim
“Clinically stable persons are defined as those who have been on ART for at least one year and show no adverse reactions to the medication to warrant regular monitoring, have no current illness or pregnancy, are not breastfeeding currently and clearly understand the lifetime treatment adherence and show success in treatment (that is, two consecutive viral load tests below 1000 copies/ml).”
Editor’s perspective
Why this matters for Georgia and the region
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, Public Health Institute of Georgia · WHO consultant, health and migration
As someone who has worked extensively on health systems strengthening in the South Caucasus, I recognize that multi-month ARV dispensing represents both an opportunity and a challenge for our region. The COVID-19 pandemic exposed vulnerabilities in our pharmaceutical supply chains, making the recommendation for 6-month safety stocks particularly relevant for countries dependent on international procurement. I would stress to Georgian colleagues the critical importance of the viral load threshold of 1,000 copies/ml measured twice consecutively—this is not merely administrative but ensures patient safety when reducing monitoring frequency. The realistic implementation caveat is storage capacity: many of our rural health posts and even urban polyclinics lack the physical space and climate control required to store 3–6 months of medication for multiple patients, so a phased rollout beginning with facilities that meet Good Storage Practice standards would be prudent.
ORCID 0000-0001-7609-4515 · Perspective written for the GMJ Guidelines Library, 19 Oct 2026
Applicability
Georgia and the South Caucasus
For Georgia and the South Caucasus, these guidelines offer a practical framework to strengthen HIV treatment continuity and decongest health facilities. National HIV programmes would need to assess local storage capacity at the primary care level, adapt prescription regulations to permit 3–6 month validity, and establish information systems capable of tracking individual patient dispensing patterns. The region’s experience with pharmaceutical supply chain management through the Global Fund and other mechanisms provides a foundation for implementing the recommended 6-month safety stock for international procurement. Countries would need to evaluate whether community-based organizations and civil society partners have sufficient capacity and training to participate in alternative dispensing modalities, and whether home delivery regulatory frameworks exist or require development similar to the Colombian model referenced in the document.
Questions this guideline answers
Quick answers
Which patients qualify for multi-month dispensing of antiretrovirals?
Clinically stable people living with HIV who have been on ART for at least one year, show no adverse reactions requiring regular monitoring, have no current illness or pregnancy, are not breastfeeding, clearly understand lifelong treatment adherence, and have two consecutive viral load tests below 1,000 copies/ml.
What safety stock levels are recommended for multi-month dispensing programmes?
Safety stock should correspond to the replenishment lead time at each level. For international procurement, a minimum safety stock of 6 months is recommended to ensure uninterrupted supply.
What documentation is required for home delivery of antiretrovirals?
The patient's identification document (original) and medical prescription are needed. If the patient is absent or is a minor, medication can be delivered to another responsible adult who must show these documents plus their own identification. Delivery must be documented with patient identification, prescription date, delivery date and time, recipient identification, signature, and space for comments.
How should local facilities calculate orders for multi-month dispensing?
Calculate 3-month consumption as: pharmaceutical units required monthly for each treatment scheme × number of patients to be served × 3 months. Include additional quantity to cover lead time consumption (an additional 1–2 months of average monthly consumption).
Related on GMJ
Interconnected resources
Dictionary of Public Health
Conditions A–Z
GMJ News coverage
Quality & accreditation
Other guidelines on this topic
- Proposal for Increasing Health Care Coverage for Venezuelan Refugees and Migrants Living with HIV. Update in Response to the COVID-19 Pandemic
- Guideline for the Treatment of Leishmaniasis in the Americas
- Updated Recommendations for Determining the Number of People with HIV Receiving Antiretroviral Therapy, September 2021
- Silence can be damaging: How to talk about monkeypox without doing harm
- Guidance on Clinical Suspicion and Differential Diagnosis of Monkeypox
- Issuer
- Pan American Health Organization
- Type
- Procedures, manuals, guidelines
- Edition
- Version 1, 23 July 2020
- Status
- Current
- Published
- 2020-01-01
- Scope
- Multi-month prescription, distribution and dispensing of antiretrovirals within integrated drug supply management systems
- Audience
- Drug supply management units, pharmacotherapy committees, national and local HIV/AIDS programmes, comprehensive care services, pharmaceutical services, community partners
- Licence
- CC BY-NC-SA 3.0 IGO
- Evidence
- Expert consensus based on WHO differentiated care strategy
- Record history
- Created 19 Oct 2026 · updated 19 Oct 2026 · next check Apr 2027
Pan American Health Organization. Guidelines for the implementation of multi-month dispensing of antiretrovirals. Version 1, 23 July 2020. Washington, D.C.: PAHO; 2020. PAHO/CDE/HSS/COVID-19/20-0037.GMJ Guidelines Library records are original summaries written by the GMJ editorial team from the issuer’s published document and reviewed by a physician. They do not replace the full guideline. The document is the copyright of its issuer and is linked, not hosted. Spotted an error or a newer edition? Tell the Guidelines Desk.
Was this article helpful?
